Erin K. O'Shea | |
---|---|
![]() | |
Education | Smith College (BS) Massachusetts Institute of Technology (MS, PhD) |
Awards | NAS Award in Molecular Biology (2001) |
Scientific career | |
Fields | Biochemistry |
Institutions | Harvard University Howard Hughes Medical Institute |
Doctoral advisor | Peter S. Kim |
Other academic advisors | Robert Tjian Ira Herskowitz |
Erin K. O'Shea is an American biologist who is president of the Howard Hughes Medical Institute (HHMI). In 2013, she was named HHMI's vice president and chief scientific officer. Prior to that, she was a professor of molecular and cellular biology and chemistry and chemical biology at Harvard University. In 2016, her appointment as future, and first woman, president of HHMI was announced. [1] She has been a Howard Hughes Medical Institute (HHMI) investigator since 2000. [2]
Erin O'Shea is one of five children, born in Leroy, New York. [3]
O'Shea earned her Bachelor of Arts in biochemistry from Smith College in 1988 and her PhD in chemistry from MIT in 1992 at age 26 [4] [3] working with Peter S. Kim studying leucine zippers. She was a postdoctoral fellow at University of California, Berkeley from 1992 to 1993. [4]
During her postdoctoral fellowship, O'Shea worked with Robert Tjian and Ira Herskowitz studying chromatin regulation of transcription in yeast. [5] When she was joined by her graduate school colleague Jonathan Weissman, they began to determine the location and abundance of all of the proteins in the yeast genome. They ultimately made two libraries both with GFP-fused protein with tandem affinity purification (TAP)-tags. [6] [7]
After her PhD, O'Shea was briefly a Basic Research Fellow before joining the faculty of University of California, San Francisco as an assistant professor in 1993. [8]
In 2005, she was recruited to Harvard University to be the director of the (FAS) Center for Systems Biology and a professor of molecular and cellular biology and chemistry and chemical biology. Her research is focused on gene regulation and the biology of a three-protein circadian clock. In 2012, she was elected to be HHMI's new Vice President and Chief Scientific Officer leading the HHMI Investigator Program succeeding Jack Dixon. She will continue to maintain her lab at Harvard. [9] [10]
O'Shea was a Packard Foundation Fellow in 1994, [11] and won young investigator awards from the American Society for Cell Biology in 2000, [12] and the Protein Society in 2001. [13] She was selected as an HHMI investigator in 2000. [14]
In 2001, O'Shea won the NAS Award in Molecular Biology for "contributions to our understanding of signal transduction, regulation of protein movement into and out of the nucleus, and how phosphorylation controls protein activity". [15]
O'Shea was elected to the National Academy of Sciences in 2004, [16] as well as the American Academy of Arts and Sciences. [17] She was elected a member of the American Philosophical Society in 2019.
O'Shea is married to Douglas Jeffery. In 2007, she said that she runs and wakeboards, and a large motivation to move to Harvard was for the chance to teach undergrads. [18]
She trained her dog, Zambo, from when he was a puppy. Zambo became national champion and then world champion in 2011, at the Universal World Sieger Championship in Austria. [19]
Susan Lee Lindquist, ForMemRS was an American professor of biology at MIT specializing in molecular biology, particularly the protein folding problem within a family of molecules known as heat-shock proteins, and prions. Lindquist was a member and former director of the Whitehead Institute and was awarded the National Medal of Science in 2010.
The Howard Hughes Medical Institute (HHMI) is an American non-profit medical research organization based in Chevy Chase, Maryland. It was founded in 1953 by Howard Hughes, an American business magnate, investor, record-setting pilot, engineer, film director, and philanthropist, known during his lifetime as one of the most financially successful individuals in the world. It is one of the largest private funding organizations for biological and medical research in the United States. HHMI spends about $1 million per HHMI Investigator per year, which amounts to annual investment in biomedical research of about $825 million.
Eva Nogales is a Spanish-American biophysicist at the Lawrence Berkeley National Laboratory and a professor at the University of California, Berkeley, where she served as head of the Division of Biochemistry, Biophysics and Structural Biology of the Department of Molecular and Cell Biology (2015–2020). She is a Howard Hughes Medical Institute investigator.
Elaine V. Fuchs is an American cell biologist famous for her work on the biology and molecular mechanisms of mammalian skin and skin diseases, who helped lead the modernization of dermatology. Fuchs pioneered reverse genetics approaches, which assess protein function first and then assess its role in development and disease. In particular, Fuchs researches skin stem cells and their production of hair and skin. She is an investigator at the Howard Hughes Medical Institute and the Rebecca C. Lancefield Professor of Mammalian Cell Biology and Development at The Rockefeller University.
Barbara J. Meyer is a biologist and genetist, noted for her pioneering research on lambda phage, a virus that infects bacteria; discovery of the master control gene involved in sex determination; and studies of gene regulation, particularly dosage compensation. Meyer's work has revealed mechanisms of sex determination and dosage compensation—that balance X-chromosome gene expression between the sexes in Caenorhabditis elegans that continue to serve as the foundation of diverse areas of study on chromosome structure and function today.
Brigid L. M. Hogan FRS is a British developmental biologist noted for her contributions to mammalian development, stem cell research and transgenic technology and techniques. She is currently a Professor in the Department of Cell Biology at Duke University, Born in the UK, she became an American citizen in 2000.
Robert Tjian is a Hong Kong-born American biochemist best known for his work on eukaryotic transcription. He is currently professor of biochemistry and molecular biology at the University of California, Berkeley and an Investigator of the Howard Hughes Medical Institute (HHMI). On April 1, 2009, Tjian became the President of HHMI. On August 4, 2015, he announced that he would step down as President at the end of 2016.
Angelika Amon was an Austrian American molecular and cell biologist, and the Kathleen and Curtis Marble Professor in Cancer Research at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Amon's research centered on how chromosomes are regulated, duplicated, and partitioned in the cell cycle. Amon was elected to the American Academy of Arts and Sciences in 2017.
Tom Abraham Rapoport is a German-American cell biologist who studies protein transport in cells. Currently, he is a professor at Harvard Medical School and a Howard Hughes Medical Institute investigator. Born in Cincinnati, Ohio, he grew up in East Germany. In 1995 he accepted an offer to become a professor at Harvard Medical School. In 1997 he became an investigator of the Howard Hughes Medical Institute. He is a member of the American and German National Academies of Science.
Douglas E. Koshland is a professor of molecular and cellular biology at the University of California, Berkeley.
Karolin Luger is an Austrian-American biochemist and biophysicist known for her work with nucleosomes and discovery of the three-dimensional structure of chromatin. She is a Distinguished Professor at the University of Colorado Boulder in the Biochemistry Department.
Jonathan S. Weissman is the Landon T. Clay Professor of Biology at the Massachusetts Institute of Technology, a member of the Whitehead Institute, and a Howard Hughes Medical Institute Investigator. From 1996 to 2020, he was a faculty member in the department of cellular molecular pharmacology at the University of California, San Francisco.
Dana Pe'er, Chair and Professor in Computational and Systems Biology Program at Sloan Kettering Institute is a researcher in computational systems biology. A Howard Hughes Medical Institute (HHMI) Investigator since 2021, she was previously a professor at Columbia Department of Biological Sciences. Pe'er's research focuses on understanding the organization, function and evolution of molecular networks, particularly how genetic variations alter the regulatory network and how these genetic variations can cause cancer.
Tracy L. Johnson is the Keith and Cecilia Terasaki Presidential Endowed Chair in the Life Sciences and Professor of Molecular, Cell, and Developmental Biology at the University of California, Los Angeles (UCLA). She is also a professor of the Howard Hughes Medical Institute. In May 2020, she was named Dean of the UCLA Division of Life Sciences.
Joan S. Brugge is the Louise Foote Pfeiffer Professor of Cell Biology and the Director of the Ludwig Center at Harvard Medical School, where she also served as the Chair of the Department of Cell Biology from 2004 to 2014. Her research focuses on cancer biology, and she has been recognized for her explorations into the Rous sarcoma virus, extracellular matrix adhesion, and epithelial tumor progression in breast cancer.
Cynthia Wolberger is an American structural biologist currently at Johns Hopkins University School of Medicine and an Elected Fellow of the American Association for the Advancement of Science. On April 19, 2019, she was elected as a member of the National Academy of Science among 100 new members and 25 foreign associates. She received her undergraduate degree in Physics from Cornell University in 1979 and her Ph.D. in Biophysics at Harvard University in 1987. She completed postdoctoral work at the University of California, San Francisco (1987-1989) and the Johns Hopkins School of Medicine (1989-1991). Her research concentrations include structural biology, ubiquitin signaling, and transcription regulation. Significant progress has been made by Wohlberger in understanding the structural biology of gene and protein control.
Catherine (Cathy) Drennan is an American biochemist and crystallographer. She is the John and Dorothy Wilson Professor of Biochemistry professor at the Massachusetts Institute of Technology and a professor at the Howard Hughes Medical Institute.
Samara Reck-Peterson is an American cell biologist and biophysicist. She is a Professor of Cellular and Molecular Medicine and Cell and Developmental Biology at the University of California, San Diego and an Investigator of the Howard Hughes Medical Institute. She is known for her contributions to our understanding of how dynein, an exceptionally large motor protein that moves many intracellular cargos, works and is regulated. She developed one of the first systems to produce recombinant dynein and discovered that, unlike other cytoskeletal motors, dynein can take a wide variety of step sizes, forward and back and even sideways. She lives in San Diego, California.
Rachel Green is a Bloomberg Distinguished Professor of molecular biology and genetics at the Johns Hopkins University School of Medicine. Her research focuses on ribosomes and their function in translation. Green has also been a Howard Hughes Medical Institute investigator since 2000.
Gia Voeltz is an American cell biologist. She is a professor of Molecular, Cellular and Developmental Biology at the University of Colorado Boulder and a Howard Hughes Medical Institute Investigator. She is known for her research identifying the factors and unraveling the mechanisms that determine the structure and dynamics of the largest organelle in the cell: the endoplasmic reticulum. Her lab has produced paradigm shifting studies on organelle membrane contact sites that have revealed that most cytoplasmic organelles are not isolated entities but are instead physically tethered to an interconnected ER membrane network.